From Gut to Brain: Uncovering Potential Serum Biomarkers Connecting Inflammatory Bowel Diseases to Neurodegenerative Diseases
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25115676 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Oliviu-Florentiu Sarb und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Iuliu Hatieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania. Hauptthemen laut MEDLINE: Biomarkers, Neurodegenerative Diseases, Inflammatory Bowel Diseases, Brain-Gut Axis. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 254 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Inflammatory bowel diseases (IBDs) are characterized by chronic gastrointestinal inflammation due to abnormal immune responses to gut microflora. The gut–brain axis is disrupted in IBDs, leading to neurobiological imbalances and affective symptoms. Systemic inflammation in IBDs affects the brain’s inflammatory response system, hormonal axis, and blood–brain barrier integrity, influencing the gut microbiota. This review aims to explore the association between dysregulations in the gut–brain axis, serum biomarkers, and the development of cognitive disorders. Studies suggest a potential association between IBDs and the development of neurodegeneration. The mechanisms include systemic inflammation, nutritional deficiency, GBA dysfunction, and the effect of genetics and comorbidities. The objective is to identify potential correlations and propose future research directions to understand the impact of altered microbiomes and intestinal barrier functions on neurodegeneration. Serum levels of vitamins, inflammatory and neuronal damage biomarkers, and neuronal growth factors have been investigated for their potential to predict the development of neurodegenerative diseases, but current results are inconclusive and require more studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuroscience, Iuliu Hatieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
- Department of Internal Medicine, 4th Medical Clinic, Iuliu Hatieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
- Department of Internal Medicine, Heart Institute, Iuliu Hatieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
- Department of Proteomics and Metabolomics, MEDFUTURE Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
ORCID-Profile: Oliviu-Florentiu Sarb, Maria Iacobescu, Mircea-Vasile Milaciu
Zitieren
APA
Sarb, O. F., Sarb, A. D., Iacobescu, M., Vlad, I. M., Milaciu, M. V., Ciurmarnean, L., Vacaras, V., & Tantau, A. I. (2024). From Gut to Brain: Uncovering Potential Serum Biomarkers Connecting Inflammatory Bowel Diseases to Neurodegenerative Diseases. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25115676
Vancouver
Sarb OF, Sarb AD, Iacobescu M, Vlad IM, Milaciu MV, Ciurmarnean L, et al. From Gut to Brain: Uncovering Potential Serum Biomarkers Connecting Inflammatory Bowel Diseases to Neurodegenerative Diseases. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25115676
BibTeX
@article{Sarb2024,
author = {Sarb, Oliviu-Florentiu and Sarb, Adriana-Daniela and Iacobescu, Maria and Vlad, Irina-Maria and Milaciu, Mircea-Vasile and Ciurmarnean, Lorena and Vacaras, Vitalie and Tantau, Alina-Ioana},
title = {From Gut to Brain: Uncovering Potential Serum Biomarkers Connecting Inflammatory Bowel Diseases to Neurodegenerative Diseases},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25115676}
}
EUVIMED